Zobrazeno 1 - 10
of 1 878
pro vyhledávání: '"C Piscitelli"'
Autor:
Barone, C. M.
Publikováno v:
Il Foro Italiano, 1971 May 01. 94(5), 1235/1236-1241/1242.
Externí odkaz:
https://www.jstor.org/stable/23160459
Publikováno v:
Il Foro Italiano, 1950 Jan 01. 73, 937/938-939/940.
Externí odkaz:
https://www.jstor.org/stable/23140009
Publikováno v:
Il Foro Italiano, 1920 Jan 01. 45, 445/446-451/452.
Externí odkaz:
https://www.jstor.org/stable/23120954
Publikováno v:
Il Foro Italiano, 1882 Jan 01. 7, 981/982-983/984.
Externí odkaz:
https://www.jstor.org/stable/23089446
Autor:
Landman, David
Publikováno v:
Clinical Infectious Diseases, 2001 Apr . 32(8), 1245-1245.
Externí odkaz:
https://www.jstor.org/stable/4461576
Autor:
Stephanie Dundas
Publikováno v:
British Journal of Clinical Pharmacology. 75:871-871
I have reviewed the Third Edition of Drug Interactions in Infectious Diseases from my perspective as a consultant physician practicing in the management of patients with community and hospital acquired infection and blood borne viruses. Potential dru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a5cd95b949db5f8080ff30d3eb985a7
https://doi.org/10.1111/j.1365-2125.2012.04412.x
https://doi.org/10.1111/j.1365-2125.2012.04412.x
Autor:
David Landman, Gary P. Wormser
Publikováno v:
Clinical Infectious Diseases. 32:1245-1245
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f009df3ed9ac54d78444f8535499fccd
https://doi.org/10.1086/319764
https://doi.org/10.1086/319764
Autor:
Amy Paller, Adelaide A Hebert, John E Jett, Philip M Brown, David S Rubenstein, Stephen C Piscitelli
Publikováno v:
British Journal of Dermatology. 188
There is a need for efficacious non-steroidal topical therapies for atopic dermatitis (AD) without restrictions relating to duration, the extent of use and application sites. Tapinarof (VTAMA®; Dermavant Sciences, Inc., USA) is a first-in-class, non
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56b2420e2f99858cfb1436ce72acf535
https://doi.org/10.1093/bjd/ljac140.005
https://doi.org/10.1093/bjd/ljac140.005
Autor:
Bruce Strober, Linda Stein Gold, Robert Bissonnette, April W. Armstrong, Leon Kircik, Stephen K. Tyring, Stephen C. Piscitelli, Philip M. Brown, David S. Rubenstein, Anna M. Tallman, Mark G. Lebwohl
Publikováno v:
Journal of the American Academy of Dermatology. 87(4)
Tapinarof cream 1% once daily, an aryl hydrocarbon receptor-modulating agent, was significantly more efficacious than vehicle and well tolerated in two 12-week phase 3 trials in adults with mild to severe plaque psoriasis.To assess long-term safety,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c250de2bd097c2a32ea1ff18aeec4156
https://pubmed.ncbi.nlm.nih.gov/35772599
https://pubmed.ncbi.nlm.nih.gov/35772599
Autor:
Mark G. Lebwohl, Linda Stein Gold, Bruce Strober, Kim A. Papp, April W. Armstrong, Jerry Bagel, Leon Kircik, Benjamin Ehst, H. Chih-ho Hong, Jennifer Soung, Jeff Fromowitz, Scott Guenthner, Stephen C. Piscitelli, David S. Rubenstein, Philip M. Brown, Anna M. Tallman, Robert Bissonnette
Publikováno v:
The New England journal of medicine. 385(24)
Tapinarof cream is a topical aryl hydrocarbon receptor-modulating agent under investigation for the treatment of psoriasis. Tapinarof modulates the expression of interleukin-17 and the skin-barrier proteins filaggrin and loricrin.We conducted two ide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18d7252131be8b47a7d33e3b54d45b38
https://pubmed.ncbi.nlm.nih.gov/34879453
https://pubmed.ncbi.nlm.nih.gov/34879453